We are live on ! Find out more
RA

Ramius Advisors Portfolio holdings

AUM $95.2M
1-Year Est. Return 7.33%
This Fund
S&P 500
This Quarter Est. Return
-7.46%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
10 Year Est. Return
AUM
$395M
AUM Growth
+$163M
Cap. Flow
+$280M
Cap. Flow %
71%
Top 10 Hldgs %
67.83%
Holding
102
New
40
Increased
17
Reduced
4
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 26.19%
2 Healthcare 17%
3 Consumer Discretionary 12.6%
4 Industrials 10.7%
5 Financials 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTD
76
DELISTED
TD Ameritrade Holding Corp
AMTD
-55,760
Closed -$2.77M
LOGM
77
DELISTED
LogMein, Inc.
LOGM
-20,997
Closed -$1.8M
DNR
78
CALL
DELISTED
Denbury Resources, Inc.
DNR
-18,100
Closed -$1K
AGN
79
PUT
DELISTED
Allergan plc
AGN
-227,100
Closed -$84K
TGE
80
PUT
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
-159,600
Closed -$8K
RTN
81
PUT
DELISTED
Raytheon Company
RTN
-25,000
Closed -$7K
RARX
82
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-55,487
Closed -$2.6M
S
83
DELISTED
Sprint Corporation
S
-1,174,868
Closed -$6.12M
AVX
84
DELISTED
AVX Corporation
AVX
-154,722
Closed -$3.17M
AVX
85
PUT
DELISTED
AVX Corporation
AVX
-7,100
Closed -$1K
PEGI
86
DELISTED
Pattern Energy Group Inc. Class A
PEGI
-30,000
Closed -$803K
INXN
87
DELISTED
Interxion Holding N.V.
INXN
-4,000
Closed -$335K
ZAYO
88
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-570,547
Closed -$19.8M
DPLO
89
CALL
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-117,900
Closed -$6K
CBPX
90
PUT
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
-114,500
Closed -$157K
ACHN
91
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
-1,250,000
Closed -$63K
ACHN
92
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
-16,000
Closed -$1K
THOR
93
CALL
DELISTED
Synthorx, Inc. Common Stock
THOR
-33,500
Closed -$28K
THOR
94
DELISTED
Synthorx, Inc. Common Stock
THOR
-9,235
Closed -$645K
THOR
95
PUT
DELISTED
Synthorx, Inc. Common Stock
THOR
-34,900
Closed -$2K
WCG
96
DELISTED
Wellcare Health Plans, Inc.
WCG
-36,158
Closed -$11.9M
ARQL
97
CALL
DELISTED
Arqule Inc
ARQL
-125,000
Closed -$16K
ARQL
98
DELISTED
Arqule Inc
ARQL
-29,981
Closed -$598K
ARQL
99
PUT
DELISTED
Arqule Inc
ARQL
-149,600
Closed -$7K
BOLD
100
DELISTED
Audentes Therapeutics, Inc
BOLD
-220,784
Closed -$13.2M

Similar funds

Ramius Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Ramius Advisors held 102 positions worth $395M, up 70% from $233M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Ramius Advisors deployed $280M of net new capital in Q1 2020, opening 40 new positions and adding to 17 existing holdings. Its largest new stake was Taubman Centers Inc.: 594,441 shares worth $24.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was WABCO HOLDINGS INC., an estimated $5.52M trimmed.

  • Ramius Advisors's largest Q1 2020 buy was Taubman Centers Inc.: 594,441 shares worth $24.9M.
  • Ramius Advisors added most to KEMET Corporation in Q1 2020, an estimated $33.6M increase.
  • Ramius Advisors's biggest Q1 2020 reduction was WABCO HOLDINGS INC., cutting an estimated $5.52M.
  • Ramius Advisors fully exited Medicines Co in Q1 2020, selling an estimated $35.7M.
  • Ramius Advisors's ten largest holdings make up 68% of its $395M portfolio in Q1 2020.
  • Ramius Advisors opened 40 new positions and closed 41 in Q1 2020.
  • Ramius Advisors's portfolio value rose 70% quarter-over-quarter to $395M.

Based on Ramius Advisors's 13F filing for Q1 2020, filed 14 May 2020.